Vertex Pharmaceuticals (VRTX)

Stock-Based Compensation

$170.20M

Quarterly · Period ending: · USD

VRTX logo

VRTX Stock-Based Compensation

Latest reported$170.20M
VRTX Quarterly Stock-Based Comp ($0.00 → $170.20M)
High-resolution chart · PNG

VRTX stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
170,200,000
166,400,000
157,600,000
194,899,999
167,300,000
166,100,000
167,800,000
184,600,000
154,200,000
191,900,000
208,600,000
130,900,000
119,300,000
122,400,000
111,500,000
135,600,000
113,900,000
130,300,000
118,608,000
102,996,000
104,622,000
115,174,000
97,027,000
99,539,000
117,189,000
115,706,000
91,591,000
85,420,000
89,687,000
93,791,000
78,943,000
85,532,000
82,436,000
78,136,000
75,402,000
73,770,000
72,582,000
68,982,000
59,082,000
61,209,000
61,942,000
55,472,000
44,646,000
65,734,000
63,261,000
57,384,000
42,382,000
46,136,000
42,444,000
46,580,000
23,370,000
31,308,000
41,350,000
31,275,000
19,566,000
30,183,000
34,556,000
29,980,000
31,183,000
31,402,000
34,602,000
29,564,000
25,212,000
25,185,000
26,534,000
20,745,000
13,141,000
21,408,000
28,726,000
23,447,000
57,985,000
0
0
13,072,000
0
0
7,724,000
12,320,000
39,137,000
0
0
8,125,000
7,530,000
915,000
0
1,435,000
0
0
0
778,000
0
0
0
799,000
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.